1 unchanged sentence
Market Information
−Removed: Our common stock has been listed on the Nasdaq Capital Market under the symbol “KRYS” since September 2017.
−Removed: Prior to that, there was no public market for our common stock.
−Removed: On February 20, 2023, there were two stockholders of record of our common stock.
−Removed: We are unable to estimate the total number of stockholders represented by these record holders, as many of our shares are held by brokers and other institutions on behalf of our stockholders.
−Removed: The closing price of our common stock was $78.25 per share as of February 20, 2023 as reported on the Nasdaq Capital Market.
+Added: Our common stock trades on the NASDAQ Global Select Market under the symbol KRYS.
+Added: Holders of Record
+Added: As of February 19, 2024, there were two stockholders of record of our common stock.
+Added: The actual number of stockholders is greater than this number of record holders, and includes stockholders who are beneficial owners, but whose shares are held in street name by brokers and other nominees.
+Added: This number of holders of record also does not include stockholders whose shares may be held in trust by other entities.
Dividend Policy
5 unchanged sentences
Sales of Unregistered Securities
−Removed: There were no sales of unregistered securities by us during the last three calendar years.
+Added: There have been no sales of unregistered securities by us during the past three years except as previously disclosed on prior Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.
Stock Performance Graph
Set forth below is a graph comparing the cumulative total return on an indexed basis of a $100 investment in the Company’s common stock, the Nasdaq Composite Index and the Nasdaq Biotechnology Index commencing on December 31, 2018 and continuing through December 31, 2023.
−Removed: The graph assumes our closing sale price on December 31, 2017 of $10.52 per share as the initial value of our common stock for indexing purposes.
+Added: The graph assumes our closing sale price on December 31, 2018 of $20.78
+Added: per share as the initial value of our common stock for indexing purposes.
Points on the graph represent the performance as of the last business day of each of the months indicated.
5 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.